Director Ezra Friedberg (PTHS) files amended RSU equity grants
Rhea-AI Filing Summary
Friedberg Ezra M reported acquisition or exercise transactions in this Form 4 filing.
Pelthos Therapeutics director Ezra M. Friedberg reported amended share awards tied to board compensation. The Form 4/A reclassifies prior filings so that restricted stock units (RSUs) granted under the 2023 Equity Incentive Plan now appear in the non-derivative table, each RSU delivering one share of common stock as it vests.
RSU awards cover 19,108 shares on July 2, 2025, 2,454 shares on November 13, 2024, and 6,450 shares on June 14, 2024, all at a stated price of $0.00 per share as compensation. These RSUs vest in equal quarterly installments over three years, subject to continued service. After the most recent award, Friedberg directly holds 82,585 common shares, with additional indirect holdings reported as 82,072 shares through Balmoral Financial Group LLC and 40,000 shares through Key Recovery Group LLC, which he may be deemed to beneficially own but disclaims except for his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 19,108 | $0.00 | -- |
| Grant/Award | Common Stock | 2,454 | $0.00 | -- |
| Grant/Award | Common Stock | 6,450 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- From June 18, 2024 to July 7, 2025, the reporting person filed multiple Form 4s relating to shares of common stock, par value $0.0001 per share ("Common Stock") of Pelthos Therapeutics Inc. (the "Issuer"), issuable upon settlement of restricted stock units of the Issuer ("RSUs") granted to the reporting person pursuant to the Issuer's 2023 Equity Incentive Plan, as amended from time to time (the "2023 Plan"), each of which represents the right to receive one (1) share of Common Stock, subject to the vesting terms of such RSUs, and may be settled solely in shares of Common Stock. The original grant of RSUs was reported in Table II of the Form 4s filed by the reporting person (the "Original Form 4s"). This Form 4 amendment (this "Amendment") is being filed to amend the Original Form 4s in order to report the grant of such RSUs in Table I. The RSUs were received as compensation for the reporting person's service as a member of the Issuer's board of directors pursuant to the 2023 Plan. The RSUs vest in equal installments on a quarterly basis after the date of such grant for a period of three years, so long as the reporting person remains in the service of the Issuer on each such anniversary. Amounts have been adjusted to reflect the 1-for-10 reverse stock split effected by the Issuer on July 1, 2025. Ezra Friedberg is the manager of Balmoral Financial Group LLC ("Balmoral") and the manager of Key Recovery Group LLC ("Key"). By virtue of these relationships, Mr. Friedberg may be deemed to beneficially own the shares of Common Stock held of record by each of Balmoral and Key. Mr. Friedberg disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.